Breast Cancer Presentations at Benghazi Medical Center Oncology Department, 2020-2023

Background: Breast cancer is the second most common cancer worldwide, the most frequent among women, and the leading cause of cancer death in females globally.Aim: This study aims to examine the pattern of breast cancer in patients who presented to the oncology department at Benghazi Medical Center (BMC) from January 1, 2020, to December 31, 2023.Patients and Methods: The study is a descriptive, retrospective cross-sectional analysis. Data were collected from 100 breast cancer patient records at BMC, selected from a total of 1,472 registered cases. Patients included in the study had confirmed diagnoses of breast cancer by histopathology. (Adding pictures from Al Noon Laboratory).Results: Out of 100 breast cancer patients registered at the oncology department, 90 were from Benghazi, and 10 were from outside the city. The majority (45%) were aged 40 to 49. Invasive ductal carcinoma was the most common type, found in 89% of cases. Among these, 47% were in Grade II, and 56% were in Stage II. Positive estrogen receptor status was observed in 93% of cases, while 53% had positive progesterone receptor status. Additionally, 78% of patients were negative for human epidermal growth factor receptor 2 (HER2), and 30% had a Ki-67 level between 10-25%.Conclusions: Most breast cancer cases at BMC were from Benghazi. The highest frequency was in the 40-49 age group, with most cases being invasive ductal carcinoma, HER2 negative, ER positive, and PR positive, and predominantly in Grade II and Stage II.